Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer Discov. 2014 Jan; 4(1):80-93.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Cell Line, Tumor
Clonal Evolution
Drug Resistance, Neoplasm
Female
Humans
Imidazoles
Indoles
Male
Melanoma
Middle Aged
Mitogen-Activated Protein Kinases
Oximes
Phosphatidylinositol 3-Kinases
Protein Kinase Inhibitors
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins c-akt
PTEN Phosphohydrolase
ras Proteins
Skin Neoplasms
Sulfonamides
authors with profiles
Thinle Chodon
Richard Koya